The Blunt Truth

FEBRUARY 10, 2022

The Hemp Advancement Act of 2022 would allow hemp to contain 1% THC, up from 0.3% The bill would also permit non-DEA labs to test the crop for THC, and would count delta-8 in allowable THC amounts. Chellie Pingree (D-ME) introduced a bill this week that would address several hemp industry concerns. currently. and finally.

Hemp 111

Hemp DEA THC Banking 111

Cannabis Law Report

FEBRUARY 5, 2022

The DEA released a proposed rule change on January 14 to put an impenetrable-looking group of substances—4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT—into Schedule I. 2022-00713. The DEA is accepting written and oral feedback on its proposed rule change until February 14. In response, the DEA raided their lab in 1994.

DEA 72

DEA Law Marijuana 72

The Blunt Truth

SEPTEMBER 10, 2021

Nevada will open cannabis lounges in 2022. The DEA would like to increase the production quota for marijuana used for research. We’re still looking at a 2022 rollout of adult-use sales. If you’re planning a trip to Nevada, you may want to wait until 2022. We have an update on New York’s cannabis agencies. new york.

Research and Development 124

Research and Development DEA Consumption State Laws 124

Americans for Safe Access

JULY 22, 2024

Healthcare Experts & Cannabis Stakeholders Clear the Smoke on Cannabis Scheduling: Join a Physician, Pharmacist, Researcher, Caregiver, Veteran, Patients, and Patient Advocates as They Bring the Rescheduling Debate to Life Washington, DC – Public comment closes today on the Department of Justice’s (DOJ) proposed rule to move cannabis (marijuana) (..)

Media 130

Media DEA Patients Marijuana 130

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 106

Vaping Research and Development Data Business 106

The Blunt Truth

JANUARY 26, 2021

Below are some highlights from the final rule: DEA Certification Requirement. Consistent with the interim final rule, the final rule requires DEA certification for laboratories testing hemp for THC levels and purity. This will most likely result in fewer laboratories available overall for hemp testing. The USDA did not raise the 0.3%

Hemp 115

Hemp DEA THC Agriculture 115

Cannabis Law Report

JULY 12, 2022

As reported by Kyle Jaeger in Filter , the DEA has set a public hearing for August 22nd, during which any person who can demonstrate they would be “adversely affected or aggrieved” by the proposed scheduling of five tryptamines can ask to testify. Source Psychedelic Alpha.

DEA 52

DEA 52

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

MAY 6, 2023

Including Bright Green, eight entities are now registered with the DEA as federally licensed cannabis “bulk manufacturers.” 31, 2022 – has announced plans […] Drug Enforcement Administration has officially registered publicly traded Bright Green Corp. as a federally licensed cannabis cultivator and product manufacturer.

DEA 52

DEA Cultivation Cannabis 52

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. billion by 2022. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

The Blunt Truth

OCTOBER 15, 2019

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% That laboratory informed plaintiff that it could not run the tests on the Dixie X as the substance was illegal and contained THC levels well over the federal limit as per DEA regulations.

THC 87

THC CBD DEA Policy 87

The Cannigma

AUGUST 16, 2022

A bill introduced in January 2022 to legalize cannabis failed , but the state is exploring regulating and decriminalizing delta-9 products and restricting delta-8 products in the 2022 fall session. Medical: No Recreational: No Reciprocity: N/A. Indiana does not have a legal medical or adult-use cannabis program. Possible penalties.

Hemp 99

Hemp DEA Programs Cannabis 99

Cannabis Law Report

MAY 16, 2022

Researchers want to force DEA to complete import application evaluation. federal court for an injunction ordering the DEA to make a final determination on an application to import and study cannabis, alleging the agency is in violation of its own rules. The Detroit News. MMJ International Holdings is asking a R.I. 2019 and Nov.

Hemp 52

Hemp CBD DEA Legalization 52

Cannabis Law Report

JULY 18, 2022

July 18, 2022. By Robert Szyba & Sydney Jenkins. One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green. million marijuana plants and conducted more than 6,600 marijuana related arrests.

DEA 52

DEA Data Decriminalization Legalization 52

TheAnswerPage

JULY 31, 2022

Describe some of the proposed changes in federal oversight that deal with the Drug Enforcement Agency (DEA). The federal jurisdiction would be transferred from the Drug Enforcement Agency (DEA) to the Food and Drug Administration (FDA) and the Alcohol and Tobacco Tax and Trade Bureau within the Treasury Department.

DEA 40

DEA Food Patients Legalization 40

Cannabis Law Report

DECEMBER 21, 2021

It was officially listed on the NYSE in August and granted a DEA schedule I manufacturing license in November. 10 Psychedelic Companies To Watch In 2022. It made progress on its investigational new drugs, CYB003 and CYB004, and filed several patents on novel molecules and delivery mechanisms.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JANUARY 31, 2023

There’s still time to register for our free webinar, discussing the Drug Enforcement Administration (DEA)’s quiet acknowledgement of the federal legality of cannabis seeds in 2022, and how this news has created a state-federal disconnect.

DEA 52

DEA Legalization Cannabis 52

Veriheal

DECEMBER 27, 2022

In light of this, the Drug Enforcement Administration (DEA) has announced its intention to substantially increase the production quota of psychedelics such as LSD, psilocybin, and mescaline due to be studied in 2023. . ” This defines one’s ability to connect to the natural world and identify nature as an essential part of life.

Research and Development 102

Research and Development Therapy Consumption DEA 102

Veriheal

NOVEMBER 6, 2023

However, the state’s legislative landscape is evolving, with the passage of a bill to fully legalize medical cannabis in 2022. According to a 2022 survey, 54% of Wyoming’s residents endorse cannabis legalization for recreational use. Sale and Delivery, meanwhile, result in felony charges.

Legalization 119

Legalization Recreational THC CBD 119

Cannabis Law Report

NOVEMBER 17, 2022

This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions and more Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp.

Pharmaceutical 52

Pharmaceutical Research and Development DEA Cannabinoids 52

Veriheal

SEPTEMBER 9, 2021

The market’s projected start date is May 2022. From April 1, 2022, cannabis consumers in New Mexico will be able to legally buy their bud from the state’s adult-use retail stores. Contingent on reenactments in 2022, specific license caps will be implemented for Virginia’s adult-use cannabis program. New Mexico.

Legalization 111

Legalization Recreational Business Retail 111

Cannabis Law Report

NOVEMBER 3, 2021

Ruis is scheduled to be sentenced on March 2, 2022. Three additional defendants have pleaded guilty to their roles in the conspiracy and will be sentenced on December 1 and January 5, 2022. Luxury vehicles, including a Ferrari belonging to Ruis, were also seized. He faces a maximum penalty of 20 years in prison.

Cannabinoids 98

Cannabinoids Packaging DEA Law 98

Cannabis Law Report

JANUARY 13, 2022

Happy 2022! In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. This DEA guidance and the Kansas opinion both suggest legality for some hemp-derived delta-8 products under the 0.3 McGuireWoods LLP. Newsworthy Highlights. Montana: As of Jan.

Dispensary 52

Dispensary Law Concentrates Patients 52

Veriheal

JUNE 30, 2023

Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin. The basis of the CSMAS argument stems from the findings of the 2022 Summit on Cannabinoids in College Athletics. The Summit found that cannabis does not enhance athletic performance.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Blunt Truth

JANUARY 16, 2020

The DEA is moving to offer proposed regulations for researchers who want to grow cannabis; the regulations are currently under review by the Office of Management and Budget. Their plan is to try again in 2022. One of the subjects that was top of mind for legislators at the hearing was research.

Decriminalization 60

Decriminalization DEA Hemp Legislation 60

Cannabis Law Report

APRIL 14, 2022

pursuant to Drug Enforcement Agency (DEA) or state-level programs). The ESG regulatory framework in the United States is still evolving, however, including the proposed rulemaking recently announced by the Securities and Exchange Commission (SEC) and the anticipated 2022 update to the Federal Trade Commission’s (FTC) Green Guides.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MAY 26, 2022

Date: May 25, 2022. On May 19, 2022, a three-judge panel upheld a preliminary injunction issued by the United States District Court for the Central District of California against Boyd Street Distro, LLC, which stands accused of infringing AK Futures’ trademark on “Cake”-branded Delta-8 THC vapor products. © 2022 THOMPSON HINE LLP.

THC 52

THC Hemp DEA Consumption 52

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. As it currently stands, the Controlled Substance Act makes it incredibly difficult for the DEA and outside research groups to grow cannabis products for the purpose of research.

Research and Development 64

Research and Development DEA Chronic Pain Business 64

Veriheal

AUGUST 24, 2022

In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “With their track-record of working with the U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

JULY 28, 2021

The DEA, which enforces the CSA, has indicated that it may consider delta-8 derived from hemp to be a “synthetically derived tetrahydrocannabinol” which still belongs on Schedule I of the CSA. . percent on a dry weight basis.” ” See 7 U.S.C. See 2021 NY S.B. 854, §§90-111.

THC 81

THC Hemp CBD Cannabinoids 81

Cannabis Law Report

JULY 27, 2022

July 27, 2022. As of July 2022, 38 states have legalized the medical use of cannabis to differing degrees. For this reason, the FDA and DEA have concluded that marijuana has no federally approved medical use in the U.S. By Raymond Lahoud. How Does Federal Law Affect Immigration?

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

MARCH 18, 2022

March 18, 2022. Food and Drug Administration (FDA) guidance on clinical trials, Drug Enforcement Agency (DEA) licensing, material transfer agreements and cooperative research and development agreements (CRDA). By Steve Levine & Marshall Custer.

Therapy 52

Therapy Research and Development Clinical Trials Environment 52

Cannabis Law Report

AUGUST 23, 2022

By Marshall Custer on August 22, 2022. 21-56133, 2022 WL 1574222 (9th Cir. 21-56133, 2022 WL 1574222 (9th Cir. May 19, 2022). THC threshold, not upon any other distinction such as flavor, concentration, manufacturing method, or how the DEA or any agency interprets the 2018 Farm Bill. Distro, LLC , No.

Hemp 52

Hemp DEA THC Concentrates 52

Cannabis Law Report

NOVEMBER 20, 2021

Drug Enforcement Administration (DEA), the Alabama Prescription Drug Monitoring Program maintained by Alabama Department of Public Health, and the Alabama Medical Cannabis Patient Registry System maintained by the Alabama Medical Cannabis Commission. Obtaining this permit requires the physician to: complete an application. 31 each year.

Patients 52

Patients DEA Dispensary Conditions 52

Cannabis Law Report

MAY 31, 2022

The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. 2022 Active FDA Clinical Trials and State-Regulated Systems. Journey Colab has a Phase I trial planned in 2022 for a synthetic version of mescaline. Schedule III. Peyote (mescaline).

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52